Setién-Olarra A, Marichalar-Mendia X,
Fernández-Pacheco JA, Fernández-Barriales-López M, Gainza-Cirauqui ML,
Aguirre-Urizar JM. Validation of microRNA expression profile in Oral Lichenoid
Disease through cytological samples. Med Oral Patol Oral Cir Bucal. 2019 Sep
1;24 (5):e610-4.
doi:10.4317/medoral.23020
http://dx.doi.org/doi:10.4317/medoral.23020
____________________________________________________________________________________________________________________________________________________________
References
1.
Cortés-Ramírez DA, Gainza-Cirauqui ML, Echebarria-Goikouria MA, Aguirre-Urizar
JM. Oral lichenoid disease as a premalignant condition: the controversies and
the unknown. Med Oral Patol Oral Cir Bucal. 2009; 14: E118-E122. |
|
|
|
2.
van der Waal, I. Potentially malignant disorders of the oral and
oropharyngeal mucosa; terminology, classification and present concepts of
management. Oral Oncol. 2009;45:317-323. |
|
|
|
3.
González-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus:
controversies surrounding malignant transformation. Oral Dis. 2008;14:229-243. |
|
|
|
4.
Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk
of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol.
2017;S2212-4403:31248-8. |
|
|
|
5.
Schwartz JL, Panda S, Beam C, Bach LE, Adami GR. RNA from brush oral cytology
to measure squamous cell carcinoma gene expression. J Oral Pathol Med. 2008;37:70-7. |
|
|
|
6.
Acha-Sagredo A, Jiménez Y, Bagán JV, Echebarria-Goicouria MA, Aguirre-Urizar
JM. Cytometric analysis of oral scrapings of patients with oral lichen
planus. Cytopathology. 2011;22:106-10. |
|
|
|
7.
He Q, Chen Z, Cabay RJ, Zhang L, Luan X, Chen D, et al. microRNA-21 and
microRNA-375 from oral cytology as biomarkers for oral tongue cancer
detection. Oral Oncol. 2016;57:15-20. |
|
|
|
8.
Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of
post-transcriptional regulation by microRNAs: are the answers in sight? Nat
Rev Genet. 2008;9:102-114. |
|
|
|
9.
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell.
2009;136:215-233. |
|
|
|
10.
Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor
suppressors and oncogenes. Oncogene. 2006;25:6188-6196. |
|
|
|
11.
Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, et al.
Identification of a microRNA signature associated with progression of
leukoplakia to oral carcinoma. Hum Mol Genet. 2009;18:4818-4829. |
|
|
|
12.
De Sarkar N, Roy R, Mitra JK, Ghose S, Chakraborty A, Paul RR, et al. A quest
for miRNA bio-marker: a track back approach from gingivo buccal cancer to two
different types of precancers. PLoS One. 2014;9:e104839. |
|
|
|
13.
Budhu A, Ji J, Wang XW. The clinical potential of microRNAs. J Hematol Oncol.
2010;3:37. |
|
|
|
14.
Yang Y, Li YX, Yang X, Jiang L, Zhou ZJ, Zhu YQ. Progress risk assessment of
oral premalignant lesions with saliva miRNA analysis. BMC Cancer. 2013;19:129. |
|
|
|
15.
Roy R, Singh R, Chattopadhyay E, Ray A, Sarkar ND, Aich R, et al. MicroRNA
and target gene expression based clustering of oral cancer, precancer and
normal tissues. Gene. 2016;593:58-63. |
|
|
|
16.
Shi W, Yang J, Li S, Shan X, Liu X, Hua H, et al. Potential involvement of
miR-375 in the premalignant progression of oral squamous cell carcinoma
mediated via transcription factor KLF5. Oncotarget. 2015;24:40172-85. |
|
|
|
17.
Setién-Olarra A, Bediaga NG, Acha-Sagredo A, Marichalar-Mendia X, de Pancorbo
MM, Aguirre-Urizar JM. Genomewide miRNA profiling of oral lichenoid disorders
and oral squamous cell carcinoma. Oral Dis. 2016;22:754-760. |
|
|
|
18.
Silverman S Jr. Oral lichen planus: a potentially premalignant lesion. J Oral
Maxillofac Surg. 2000;58:1286-1288. |
|
|
|
19.
Spivack SD, Hurteau GJ, Jain R, Kumar SV, Aldous KM, Gierthy JF, et al. Gene
environment interaction signatures by quantitative mRNA profiling in
exfoliated buccal mucosal cells. Cancer Res. 2004;64:6805-13. |
|
|
|
20.
Arao TC, Guimaraes AL, de Paula AM, Gomes CC, Gomez RS. Increased miRNA-146a
and miRNA-155 expressions in oral lichen planus. Arch Dermatol Res. 2012;304:371-375. |
|
|
|
21.
Gassling V, Hampe J, Acil Y, Braesen JH, Wiltfang J, Hasler R.
Disease-associated miRNA-mRNA networks in oral lichen planus. PLoSOne.
2013;8:e63015. |
|
|
|
22.
Taganov KD, Boldin MP, Chang KJ, Baltimore D. NFkappaB- dependent induction
of microRNA miR-146, an inhibitor targeted to signaling proteins of innate
immune responses. Proc Natl Acad Sci USA. 2006;103:12481-12486. |
|
|
|
23.
Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of
microRNA-146 suppresses NFkappa B activity with reduction of metastatic
potential in breast cancer cells. Oncogene. 2008;27:5643-5647. |
|
|
|
24.
Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the
regulation of normal immune function and inflammation. Semin Cancer Biol.
2008;18:131-140. |
|
|
|
25.
Zhang S, Hu F, Liang H, Liu Y, Yang J, Zhou W. Association between a
miRNA-146a polymorphism and susceptibility to head and neck squamous cell
carcinoma in Chinese patients: A meta-analysis of 8 case-control studies.
PLoS One. 2017;12:e0186609. |
|
|
|
26.
Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ, Lin SC. Association between the
rs2910164 polymorphism in premir- 146a and oral carcinoma progression. Oral
Oncol. 2012;48:404-8. |
|
|
|
27.
Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, et al.
MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway
and is down-regulated in glioblastoma. Cancer Res. 2008;68:3566-3572. |
|
|
|
28.
Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A, et al. MicroRNA-7
targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell
carcinoma cells. Biochem J. 2010;15:199-205. |
|
|
|
29.
Zhao XD, Lu YY, Guo H, Xie HH, He LJ, Shen GF, et al. MicroRNA-7/NF-κB
signaling regulatory feedback circuit regulates gastric carcinogenesis. J
Cell Biol. 2015;210:613-27. |
|
|
|
30.
Anderson EC, Wong MH. Caught in the Akt: regulation of Wnt signaling in the
intestine. Gastroenterology. 2010;139:718-722. |
|
|